Open access · OA
via OpenAlex
NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury
Tomohito Doke, Sarmistha Mukherjee, Dhanunjay Mukhi, Poonam Dhillon, Amin Abedini, James G. Davis, Karthikeyani Chellappa, Beishan Chen, Joseph A. Baur, Katalin Suszták
Nature Metabolism · 2023 · ▲ 97 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s42255-023-00761-7
- Canonical
- link ↗
- Fetched
- 2026-06-16 MST
Cite this
APA
Doke, T., Mukherjee, S., Mukhi, D., Dhillon, P., Abedini, A., Davis, J.G., Chellappa, K., Chen, B., Baur, J.A., & Suszták, K. (2023). NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury. <em>Nature Metabolism</em>. https://doi.org/10.1038/s42255-023-00761-7
Vancouver
Doke T, Mukherjee S, Mukhi D, Dhillon P, Abedini A, Davis JG, et al. NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury. Nature Metabolism. 2023. doi:10.1038/s42255-023-00761-7.
BibTeX
@article{tomohito2023NADpre,
title = {NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury},
author = {Tomohito Doke and Sarmistha Mukherjee and Dhanunjay Mukhi and Poonam Dhillon and Amin Abedini and James G. Davis and Karthikeyani Chellappa and Beishan Chen and Joseph A. Baur and Katalin Suszták},
journal = {Nature Metabolism},
year = {2023},
doi = {10.1038/s42255-023-00761-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Toxins 2021
Open access · CC-BY
Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease
Nature reviews. Immunology 2015
Preprint · OA
Eicosanoid storm in infection and inflammation
Journal of Allergy and Clinical Immunology 2020
Preprint · CC-BY
Can blocking inflammation enhance immunity during aging?
Molecular Metabolism 2019
Open access · CC-BY
A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
The FASEB Journal 2021
Open access · OA
Reduced nicotinamide mononucleotide is a new and potent NAD <sup>+</sup> precursor in mammalian cells and mice
Clinical Nutrition ESPEN 2023
Open access · CC-BY